" class="no-js "lang="en-US"> Shaun Blakeman - Medtech Alert
Wednesday, October 01, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Shaun Blakeman

Shaun Blakeman

About Shaun Blakeman

Strong leader and results oriented self-starter with over 20 years of experience. Proven record spanning finance, operations, logistics, and engineering project management. Strong financial and business analytical capabilities combined with excellent interpersonal skills. Core competencies include:

• Analytics and Modeling
• Financial Management
• Program/Project Management
• Continuous Process Improvement
• Project Costing/Budget Control
• New Process Implementation
• Change Leadership
• Personnel Management/Development

Related Story

Appointments

 SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer | Pharmtech Focus

SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer

August 3 2021

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]